Economic Support to Patients in HIV and TB Grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria

Abstract

People with TB and/or HIV frequently experience severe economic barriers to health care, including out-of-pocket expenses related to diagnosis and treatment, as well as indirect costs due to loss of income. These barriers can both aggravate economic hardship and prevent or delay diagnosis, treatment and successful outcome, leading to increased transmission, morbidity and mortality. WHO, UNAIDS and the ILO argue that economic support of various kinds is essential to enable vulnerable people to protect themselves from infection, avoid delayed diagnosis and treatment, overcome barriers to adherence, and avert destitution. This paper analyses successful country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria that include economic support in Rounds 7 and 10; 36 and 20 HIV and TB grants in Round 7 and 32 and 26, respectively, in Round 10. Of these, up to 84 percent included direct or indirect economic support for beneficiaries, although the amount constituted a very small proportion of the total grant. In TB grants, the objectives of economic support were generally clearly stated, and focused on mechanisms to improve treatment uptake and adherence, and the case was most clearly made for MDR-TB patients. In HIV grants, the objectives were much broader in scope, including mitigation of adverse economic and social effects of HIV and its treatment on both patients and families. The analysis shows that economic support is on the radar for countries developing Global Fund proposals, and a wide range of economic support activities are in place. In order to move forward in this area, the wealth of country experience that exists needs to be collated, assessed and disseminated. In addition to trials, operational research and programme evaluations, more precise guidance to countries is needed to inform evidence-based decision about activities that are cost-effective, affordable and feasible.

Barriers to Utilization of HIV Care Services Among Adolescents and Young Adults in Rakai, Uganda: the Role of Economic Strengthening

“…These mainly related to lack of money to meet transport costs to the clinic and time and money lost during the long waiting hours at the clinic. These findings are similar to other studies that have shown that people with HIV frequently experience severe economic barriers to health care, which can prevent or delay diagnosis and treatment outcome (Richter et al 2014). Transport is a known barrier for poor people to access HIV treatment and care (Mshana et al 2006;Rosen et al 2007;Tuller et al 2010).…”

Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For Improvement

“…Economic incentives to improve medication adherence and clinic appointment fidelity, such as providing direct payments or nutritional supplementation to patients, have shown modest benefit. 41,42 Efforts to target historically stigmatized populations, which often faced the highest rates of infection and mortality, attempted to reduce reservoirs for HIV. 43 Though these strategies may not be evenly applied to a NCD model, addressing SDH may similarly prove to be both successful and cost-effective.…”

System Context and Drivers Contributing to Collaborative Governance in Coping with HIV/AIDS in Surakarta Indonesia

“…The running of dynamic is determined by the activation of shared principles, shared motivation, and capacity to take joint action. Collaborative dynamics is a cycle containing components affecting the process of collaboration (Hanefeld, 2014;Richter et al, 2014;Bridge et al, 2016).…”